16093-16-6

Usage

InChI:InChI=1/C14H18O6/c1-18-11-8-7-9(13(19-2)14(11)20-3)10(15)5-4-6-12(16)17/h7-8H,4-6H2,1-3H3,(H,16,17)

Upstream product

• 5205-39-0 ethyl glutaroyl chloride 
• 634-36-6 1,2,3-trimethoxybenzene 
• 108-55-4 glutaric anhydride, 
• 412012-34-1 5-(2,3,4-trimethoxy-phenyl)-5-oxo-pentanoic acid methyl ester 

Downstream Products

• 79623-04-4 5-(3,4-dimethoxy-2-hydoxyphenyl)valeric acid 
• 859785-14-1 5-(2',3',4'-trimethoxyphenyl)pentanoic acid 
• 412012-34-1 5-(2,3,4-trimethoxy-phenyl)-5-oxo-pentanoic acid methyl ester 

Relevant academic research and scientific papers

Synthesis of diverse analogues of Oenostacin and their antibacterial activities

Several diverse analogues of Oenostacin, a naturally occurring potent antibacterial phenolic acid derivative, have been synthesized. A small library with more than forty analogues having different aromatic rings and varied side chains has been achieved through solution phase synthesis. Some of these analogues, that is, 22, 23 and 42, possessed potent antibacterial activities against Staphylococcus epidermidis and Staphylococcus aureus having EC50 ranging from 0.49 to 0.67 μM as compared to Oenostacin (EC50 = 0.12 μM).

Increasing the open circuit voltage of bulk-heterojunction solar cells by raising the LUMO level of the acceptor

We report the synthesis, characterization, and electrochemical properties of ten new fullerene derivatives for usage in organic solar cells. The phenyl ring of PCBM was substituted with electron-donating and electron-withdrawing substituents to study thei

Combretastatin analogs with tubulin binding activity

Analogs of combretastatin have been discovered which demonstrate impressive cytotoxicity as well as a remarkable ability to inhibit tubulin polymerization. Such compounds are excellent clinical candidates for the treatment of cancer in humans. In addition, certain of these ligands, as pro-drugs, may well prove to be tumor selective vascular targeting chemotherapeutic agents or to have vascular targeting activity resulting in the selective prevention and/or destruction of nonmalignant proliferating vasculature.